phenanthridone has been researched along with ovalbumin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aldinucci, A; Ballerini, C; Biagioli, T; Cavone, L; Chiarugi, A; Moroni, F | 1 |
1 other study(ies) available for phenanthridone and ovalbumin
Article | Year |
---|---|
PARP-1 inhibition prevents CNS migration of dendritic cells during EAE, suppressing the encephalitogenic response and relapse severity.
Topics: Analysis of Variance; Animals; Antigen Presentation; Autoimmunity; Cell Movement; Cells, Cultured; Central Nervous System; Cytokines; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B; Ovalbumin; Phenanthrenes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Recurrence; Severity of Illness Index; Th17 Cells; Time Factors | 2011 |